Description
Tesamorelin research peptide
Tesamorelin is a synthetic analogue of growth hormone-releasing hormone, stabilised by a trans-3-hexenoyl group at the N-terminus. It is one of the best-characterised GHRH analogues in clinical research.
Product details
| Compound | Tesamorelin |
|---|---|
| Class | Stabilised GHRH analogue |
| Format | Lyophilised peptide vial |
| Labelling | Compound name and strength on every container |
What Tesamorelin research has examined
- GHRH receptor signalling: pituitary GH release and IGF-1 response.
- Clinical research: randomised trials in specific metabolic conditions.
- Analogue design: N-terminal modification to resist enzymatic breakdown.
Research interest does not establish a proven effect in humans.
Regulatory status
Licensed medicines containing this active ingredient are prescription-only products made by authorised manufacturers. The material sold here is a research chemical, not a licensed medicine, and is not approved for any use in humans.
Storage and handling
Store lyophilised vials cold, dry and away from light. Reconstitute with a suitable sterile diluent under aseptic conditions and keep solutions refrigerated. See our peptide reconstitution guide.
Related research products
Adamax / Adalank Combo Pack · Healing Research Bundle · Turn Back Time Bundle · All peptides
References
For laboratory research use only. Not for human or animal consumption. Not intended to diagnose, treat, cure or prevent any disease.
Reviews
There are no reviews yet.